L’ACMTS tient à appuyer les décideurs du secteur de la santé canadiens durant cette période difficile et incertaine.
Pour trouver des outils, ressources et données probantes touchant la COVID-19, consultez notre portail sur la COVID-19.

 

Begin main content

Use of Metformin in Patients with Type 2 Diabetes who have Liver Dysfunction: A Review of Safety, Dosing Recommendations, and Guidelines for Use

Dernière mise à jour : 3 septembre 2008
Gamme de produits : Rapports d’examen rapide
Type de recherche : Médicaments
Type de résultat : Rapports

Question

  1. Is there evidence to support decisions on when therapy with metformin should be withheld based on liver function in patients with type 2 diabetes?
  2. What are the guidelines for the use of metformin in individuals with type 2 diabetes and liver dysfunction?
  3. How safe is metformin compared with other oral hypoglycemic drugs when used in individuals with type 2 diabetes and liver dysfunction?
  4. Is there clinical evidence to support dosing recommendations for metformin when used in individuals with type 2 diabetes and liver dysfunction?